The prospective , open , randomized controlled clinical trial ( n = @ ) will compare Triple Pill-based strategy to usual care among individuals with persistent mild-to-moderate hypertension ( systolic BP > @ mm Hg and/or diastolic BP > @ mm Hg , or systolic BP > @ mm Hg and/or diastolic BP > @ mm Hg in patients with diabetes or chronic kidney disease ) on no or minimal drug therapy .